Company Filing History:
8 out of 1,384 
2 out of 6 
1 out of 7 Years Active: 1994-2001
Title: Jurgen Conrad: Innovator in Metal-Binding Cystein-Free Peptides
Introduction:
Jurgen Conrad, a renowned inventor, researcher, and innovator, hails from Berlin, Germany. With a remarkable portfolio of 13 patents, Conrad has made significant contributions to the field of metal-binding cystein-free peptides, focusing on their diagnostic and therapeutic applications. This article delves into Conrad's latest patents, career highlights, collaborations, and the groundbreaking advancements he has made.
Latest Patents:
One of Jurgen Conrad's most notable recent patents is his invention related to metal-binding cysteine-free peptides for diagnostic and therapeutic purposes. These peptides have the ability to bind to metals and can be coupled directly or indirectly to organ-specific probes, such as antibodies or antibody fragments against tumor-associated antigens. This coupling enables the specific enrichment of these peptides in tumors, organs, tissues, or centers of inflammation. The invention also includes processes for producing these peptides and their conjugates, as well as their utilization as components in in vivo diagnostic kits or therapies. Furthermore, radio-pharmaceuticals incorporating these conjugates, along with radio-isotopes, have been developed to image tumors, organs, or centers of inflammation.
Career Highlights:
Jurgen Conrad has had a diverse and successful career, with notable contributions to the field of pharmaceutical and diagnostic research. During his professional journey, he has held positions at esteemed institutions, including the Schering Aktiengesellschaft and the Institut Fur Diagnostikforschung GmbH. Conrad's expertise in metal-binding peptides has led to groundbreaking advancements in the field, paving the way for enhanced diagnostic tools and targeted therapies.
Collaborations:
In his quest for innovation, Jurgen Conrad has collaborated with various experts in the field. Notably, he has worked closely with Heinz Gries and Heribert Schmitt-Willich, two esteemed researchers who have contributed significantly to the development and application of metal-binding cysteine-free peptides. The collaboration of these brilliant minds has been instrumental in advancing the field and bringing Conrad's inventions to fruition.
Conclusion:
Jurgen Conrad's groundbreaking inventions in metal-binding cystein-free peptides have revolutionized the field of diagnostics and therapeutics. His patents and contributions have opened up new possibilities in targeted imaging of tumors, organs, and centers of inflammation. Conrad's career highlights and collaborations with esteemed professionals testify to his expertise and dedication in the field. Through his remarkable work, Conrad continues to contribute to the advancement of healthcare by developing innovative solutions for diagnosis and therapy.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.